Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.

Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.

This study extends our previous observation that glycopeptides bind to class I major histocompatibility complex (MHC) molecules and elicit carbohydrate-specific CTL responses. The Sendai virus nucleoprotein wild-type (WT) peptide (FAPGNYPAL) binds H-2Db using the P5-Asn as an anchor. The peptide K2...

Full description

Bibliographic Details
Main Authors:	Haurum, J, Tan, L, Arsequell, G, Frodsham, P, Lellouch, A, Moss, P, Dwek, R, Mcmichael, A, Elliott, T
Format:	Journal article
Language:	English
Published:	1995

Similar Items

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes.
by: Haurum, J, et al.
Published: (1994)

T-cell receptor usage of major histocompatibility complex class I restricted peptide-specific T-lymphocytes.
by: Gerth, U, et al.
Published: (1995)

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
by: Colbert, R, et al.
Published: (1993)

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
by: Colbert, R, et al.
Published: (1993)

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
by: Braud, V, et al.
Published: (1997)

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
by: Hill, AB, et al.
Published: (1995)

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
by: Mutis, T, et al.
Published: (1999)

Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection.
by: Oldstone, M, et al.
Published: (1995)

Presentation of antigenic peptides by products of the major histocompatibility complex.
by: Fairchild, P
Published: (1998)

CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR EPSTEIN-BARR-VIRUS (EBV) NUCLEAR ANTIGENS FAIL TO LYSE THE EBV-TRANSFORMED B-LYMPHOBLASTOID CELL-LINES AGAINST WHICH THEY WERE RAISED
by: Hill, A, et al.
Published: (1995)

Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses.
by: Bowness, P, et al.
Published: (1993)

Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease.
by: Mcmichael, A
Published: (1992)

A cross-species functional interaction between the murine major histocompatibility complex class I alpha 3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytes.
by: Moots, R, et al.
Published: (1992)

Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers.
by: Lechner, F, et al.
Published: (2000)

Influence of the major histocompatibility complex on lymphocyte interactions in antibody formation.
by: Waldmann, H, et al.
Published: (1978)

Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide.
by: Vessey, S, et al.
Published: (1997)

Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport.
by: Cerundolo, V, et al.
Published: (1995)

Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients.
by: Cerundolo, V
Published: (2000)

Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules.
by: Antrobus, R, et al.
Published: (2005)

The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules.
by: Cerundolo, V, et al.
Published: (1991)

The ontogeny, structure and function of the human T lymphocyte receptor for antigen and major histocompatibility complex.
by: Reinherz, E, et al.
Published: (1986)

Kinetics of abacavir-induced remodelling of the major histocompatibility complex class I peptide repertoire
by: Illing, PT, et al.
Published: (2021)

An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide.
by: Dong, T, et al.
Published: (1996)

Cytotoxic T lymphocytes in HIV infection
by: Rowland-Jones, S, et al.
Published: (1993)

Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO.
by: van Ham, M, et al.
Published: (2000)

Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes.
by: Mcmichael, A, et al.
Published: (1986)

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
by: Klenerman, P, et al.
Published: (1995)

Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.
by: Goulder, P, et al.
Published: (1997)

HIV-gag-specific cytotoxic T lymphocytes.
by: Nixon, D, et al.
Published: (1989)

Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains.
by: Elliott, T, et al.
Published: (1992)

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
by: Townsend, A, et al.
Published: (1986)

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
by: Townsend, A, et al.
Published: (1986)

VERY HIGH-FREQUENCY OF HIV-SPECIFIC CYTOTOXIC T-CELLS IN HEMOPHILIA PATIENTS
by: Moss, P, et al.
Published: (1994)

Bioorthogonal cleavage and exchange of major histocompatibility complex ligands by employing azobenzene-containing peptides
by: Choo, Joanna A. L., et al.
Published: (2015)

Association of class I major histocompatibility heavy and light chains induced by viral peptides.
by: Townsend, A, et al.
Published: (1989)

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
by: Nixon, D, et al.
Published: (1988)

IMMUNOGENIC HIV VARIANT PEPTIDES THAT BIND TO HLA-B8 BUT FAIL TO STIMULATE CYTOTOXIC T-LYMPHOCYTE RESPONSES
by: Mcadam, S, et al.
Published: (1995)

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
by: Townsend, A, et al.
Published: (2006)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
by: Matsui, M, et al.
Published: (1994)

Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
by: Mcmichael, A, et al.
Published: (1988)